Availability, Affordability, and Prices of Smoking Cessation Products in 9 Countries: Preliminary Findings

Numerous effective medications are available for tobacco dependence treatment, and clinicians should encourage their use by all patients attempting to quit smoking. According to the FCTC Article 14 Guideline “Tobacco cessation medications should be made available to tobacco users wanting to quit and where possible be provided free or at an affordable cost”. Online survey was conducted among 9 countries (Armenia, Bangladesh, Brazil, India, Jordan, Nigeria, Spain, Turkey, Vietnam) to determine availability, affordability, and prices of smoking cessation drugs in countries that are Global Bridges grantees and to make comparisons across them. Preliminary findings of the online survey will be summarized during the presentation.

CITATIONS (1):

Smoking cessation knowledge, attitude and practices among tuberculosis physicians: A qualitative study
Arusyak Harutyunyan, Armine Abrahamyan, Zaruhi Grigoryan, Varduhi Hayrumyan, Nune Truzyan, Varduhi Petrosyan
Tobacco Prevention & Cessation

CrossRef

Submit your paper

Instructions to Authors

Home

Send by email

Staff and student experiences and attitudes towards smoking and smoking cessation, University of Jeddah, Saudi Arabia

Efficacy and safety of electronic cigarettes as a smoking cessation intervention: A systematic review and network meta-analysis

Electronic cigarette use and smoking cessation in cohort studies and randomized trials: A systematic review and meta-analysis

An innovation involving self-surveillance and serious gaming to increase smoking quit rate: Protocol for a pilot randomized controlled trial

Is the motivation to quit smoking a predictor of abstinence maintenance?

Indexes

Keywords index

Topics index

Authors index

eISSN:

2459-3087

On behalf of the European Network of Smoking and Tobacco Prevention. Chausse d'lxelles 144, Brussels, Belgium.
Published by European Publishing. Science and Technology Park of Crete (STEP-C). Vassilika Vouton, GR-70013 Heraklion, Crete, Greece

This journal is currently funded by the Health Programme of the European Union
Neither the European Commission nor any person acting on behalf of the European Commission is responsible for the use which might be made of the information contained herein. The views in this publication are those of the author and do not necessarily reflect the policies of the European Commission.

© 2022 European Publishing, unless otherwise stated.
The views and opinions expressed in the published articles are strictly those of the author(s). 21 December 2021.